Senior Data Engineer
Boehringer Ingelheim1 month ago
London, United KingdomSenior
Responsibilities
- Build and maintain entity-linking pipelines connecting patients, samples, and other biomedical entities across imaging, clinical, and multi-omics records.
- Build and maintain cross-modal integration pipelines for unified assets used in multimodal model training, fine-tuning, and inference.
- Operate pipelines and datasets in accordance with data permissions, consent conditions, usage restrictions, and controlled-access environments.
- Build and maintain versioned and documented biomedical benchmark datasets.
- Write clean, tested, and documented code, contribute to code reviews, and stay current with relevant data engineering practices.
Requirements
- PhD in Machine Learning, Computer Science, Bioinformatics, Computational Biology, or a related quantitative field.
- Strong hands-on experience in data engineering for machine learning and proficiency with modern data engineering technology stacks.
- Experience with medical imaging modalities such as radiology or histopathology, or multi-omics modalities such as transcriptomics or proteomics.
- Working knowledge of other biomedical data modalities sufficient for cross-modal integration.
- Practical experience with entity linking or record linkage, ideally in a biomedical or clinical context.
- Strong understanding of biomedical data characteristics, including variant data formats, expression matrices, SNOMED, and ICD-10.
- Familiarity with biomedical and clinical data governance frameworks and Trusted Research Environments or controlled-access data environments.
Benefits
- Hybrid role requiring three days per week in the office.
- The employer is recognised as a Top Employer in the UK and highlights supportive people practices and HR policies.
Categories
Data Engineering
About Boehringer Ingelheim
Boehringer Ingelheim develops and manufactures prescription medicines for humans and animal health products, and provides biopharmaceutical contract manufacturing services. The family-owned company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. Its portfolio spans areas such as cardiovascular and metabolic diseases, respiratory disorders, oncology, and vaccines for livestock and companion animals, with products marketed globally.